Market View 27th October, 2026

View on market: Volatility persists, eagerly searching for growth:

Asian markets traded mixed on Tuesday as investors assessed gains on Wall Street, developments in the technology sector, and upcoming economic data ahead of major central bank decisions and technology company earnings. South Korean and Japanese markets advanced strongly, supported by positive global sentiment, while Australian and New Zealand markets declined. Technology stocks remained in focus following gains on Wall Street, driven by optimism surrounding Anthropic’s IPO filing and continued strength in the technology sector. Falling oil prices also supported investor sentiment during the previous US trading session, helping major American indices close higher. Meanwhile, Indian equity benchmarks recovered from early losses to end Monday’s session in positive territory. The Nifty and Sensex gained modestly, supported by improved market sentiment. Investors will closely monitor global technology developments, corporate earnings, oil price movements, and central bank decisions for further direction. Overall, market sentiment remained mixed across Asia, with investors balancing optimism over technology stocks against uncertainty surrounding the global economic outlook and upcoming policy decisions.

Key Quarterly Results for Today:

ABDL, ACC, ACUTAAS, BAJAJ-AUTO, CIPLA, CONCORDBIO, DUNCANENG, GANDHAR, GRAVITA, GUJARATPOLY, GULFPETRO, HOMEFIRST, HUHTAMAKI, INDIAMART, INDUSTOWER, INFOMEDIA, JINDHOT, JSWINFRA, JUBLINGREA, KIRLOSBROS, LT, LTFOODS, MARUTI, MAZDOCK, MEDPLUS, MFSL, MOREPENLAB, ONESOURCE, PPLPHARMA, RADICO, RAYMOND, RAYMONDREL, SAIL, SBILIFE, SCHAEFFLER, SGMART, SKYGOLD, STARHEALTH, SYNGENE, TANLA, TATACAP, UBL, UNIMECH, WAAREEENER.

Economic Calendar:

• USD: House Price Index and ADP Employment Change Data on 27^th October 2026.
• IND: Industrial Production Data on 28^th October 2026.
• USD: Fed Monetary Policy API & EIA Crude Oil Inventory and MBA 30–Year Mortgage Rate on 28^th October 2026.
• IND: Bank Loan & Deposit Growth Rate and Foreign Reserve Data on 30^th October 2026.

BROKERAGE

JEFFERIES ON AB REAL ESTATE:

Target ₹1600 Earlier Target ₹1880 Recommendation Buy, Reported strong P&L in Q2 on a project delivery, with non-core asset sale proceeds helping turn the balance sheet nearly net cash, New project additions have picked up pace, though same will likely get launched from late FY27 onwards, Management focusing on long term value maximisation, Delay in Worli launch would impact near term pre-sales even as commercial buildout gains visibility, Stock trades at 45% NAV discount.

CITI ON PAYTM:

Target ₹1940 Earlier Target ₹1560 Recommendation Buy, Solid Growth and Margins Uptick Ahead of MDR Slingshot, Seeing growth acceleration in financial services and improvement in net payment margins even ex-UPI, Upping investments in tech (Al), marketing and distribution (MTU acquisition, on-ground sales-fleet), EBITDA beat estimates owing to higher share of financial services revenue.

INVESTEC ON SHEELA FOAM:

Target ₹625 Earlier Target ₹700 Recommendation Hold, Recent price correction has made valuation more reasonable, See 20% EPS CAGR over FY27-29, Bake in conservative revenue growth of 7% CAGR over FY26-29, average EBITDA margin at 9.7%, Issues – input-cost pressures, demand sensitivity to pricing, downtrading risks and competition from D2C mattresses with lower TDI and polyol content.

JEFFERIES ON MANKIND PHARMA:

Target ₹2900 Earlier Target ₹3220 Recommendation Buy, No Longer Waiting for Godot, Q2 results beat; strong Q2 was driven by robust domestic growth and solid export momentum, This resulted in gross margin gains and operating leverage, Domestic formulations grew 16% YoY, finally outpacing industry growth, Muted consumer healthcare growth was the only weak point in Q2.

International Markets:

U.S & Europe:

*As per 27^th October.

Asian markets

Stocks strong on Chart:

Commodities & Currency:

FIIs & DIIs:

FII & DII Data in Cr.

News Updates:

Disclaimer:

InCred Markets Limited (“the Company”), Formerly known as Elite Wealth Limited (The company is Wholly Owned Subsidiary of InCred Capital Financial Services Limited) does/ does not do business with companies covered in its research reports. Investors should be aware that the Company may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.incredmarkets.com. Analysts employed by the Company are registered/qualified as research analysts with SEBI in India. (SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Vindhyachal Prasad, InCred Markets Limited, vindhyachal@elitestock.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in the Company.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
1. All of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
2. No part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report. For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.incredmarkets.com.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all InCred Markets Limited covered companies by visiting www.incredmarkets.com. or emailing research@elitestock.com with your request. The Company may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at www.incredmarkets.com.
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
InCred Markets Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of the Company. Analyst as officer or director: The Company’s policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Use of Artificial Intelligence Tools (AI)
• The Research Analyst may use Artificial Intelligence (AI) tools, to the extent applicable, for supporting research activities such as data analysis, processing of information, research assistance and preparation of research materials.
• AI tools are used only as supporting tools in the research process. All research recommendations and services remain subject to the Research Analyst’s review, verification and professional judgment. The Research Analyst remains responsible for the research services provided, including the accuracy and integrity of the information used, protection of client data, confidentiality and compliance with applicable laws and SEBI regulations.
• The extent and nature of AI usage may vary depending on the research activity. The Research Analyst shall make additional disclosures regarding AI usage whenever required.

Country Specific Disclosures
India – For private circulation only, not for sale. Legal

Entities Disclosures
InCred Markets Limited (Formerly known as Elite Wealth Limited) (IML henceforth), is a SEBI Registered Analyst having registration no. INH100002300, having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, Telephone: 0120-4477777, and Website: www.incredmarkets.com. There is no material conflict of interest with the subject company. The company and the Research Analyst have no actual or beneficial interest of one percent or more in the subject company.

The Company discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) IML or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
b) IML or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
c) IML or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
a) IML or its associates have not received any compensation from the subject company in the past twelve months;
b) IML or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
c) IML or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
d) IML or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
e) IML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3. In respect of Public Appearances
a) IML or its associates have not received any compensation from the subject company in the past twelve months;
b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by IML